Literature DB >> 17544966

Identification of a peptide from alpha-gliadin resistant to digestive enzymes: implications for celiac disease.

Gianfranco Mamone1, Pasquale Ferranti, Mauro Rossi, Peter Roepstorff, Olga Fierro, Antonio Malorni, Francesco Addeo.   

Abstract

Current knowledge indicates that both innate and adaptive immune responses are involved in Celiac disease (CD) driven by different gliadin peptides. By studying a representative recombinant alpha-gliadin form, a further 25-mer peptide resistant to gastric, pancreatic, and human intestinal brush-border membrane enzymes was detected. This peptide latter encompasses the sequence 31-43 known to elicit the innate immune response in CD. The resistance of 25-mer, as well as that of the already described 33-mer related to the CD adaptive immune response, was confirmed on a standard flour wheat sample representative of the most widespread European varieties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544966     DOI: 10.1016/j.jchromb.2007.05.009

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  16 in total

Review 1.  Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.

Authors:  C Osorio; N Wen; R Gemini; R Zemetra; D von Wettstein; S Rustgi
Journal:  Funct Integr Genomics       Date:  2012-06-26       Impact factor: 3.410

2.  Significant Hydrolysis of Wheat Gliadin by Bacillus tequilensis (10bT/HQ223107): a Pilot Study.

Authors:  Sandip K Wagh; Praful P Gadge; Manohar V Padul
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

3.  An Effective Label-Free Electrochemical Aptasensor Based on Gold Nanoparticles for Gluten Detection.

Authors:  Rossella Svigelj; Ivan Zuliani; Cristian Grazioli; Nicolò Dossi; Rosanna Toniolo
Journal:  Nanomaterials (Basel)       Date:  2022-03-17       Impact factor: 5.076

4.  Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.

Authors:  J Huan; R Meza-Romero; J L Mooney; A A Vandenbark; H Offner; G G Burrows
Journal:  Mucosal Immunol       Date:  2010-08-25       Impact factor: 7.313

5.  Epithelial transport of immunogenic and toxic gliadin peptides in vitro.

Authors:  Christian Zimmermann; Silvia Rudloff; Günter Lochnit; Sevgi Arampatzi; Wolfgang Maison; Klaus-Peter Zimmer
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 6.  Translational Chemistry Meets Gluten-Related Disorders.

Authors:  Karen M Lammers; Maria G Herrera; Veronica I Dodero
Journal:  ChemistryOpen       Date:  2018-02-27       Impact factor: 2.911

Review 7.  Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.

Authors:  Stefania Martucciello; Silvia Sposito; Carla Esposito; Gaetana Paolella; Ivana Caputo
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

8.  A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43.

Authors:  Merlin Nanayakkara; Roberta Kosova; Giuliana Lania; Marco Sarno; Alessandra Gaito; Martina Galatola; Luigi Greco; Marialaura Cuomo; Riccardo Troncone; Salvatore Auricchio; Renata Auricchio; Maria Vittoria Barone
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

9.  Endocytosis and transcytosis of gliadin peptides.

Authors:  M Vittoria Barone; K Peter Zimmer
Journal:  Mol Cell Pediatr       Date:  2016-02-16

10.  P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: a role in celiac disease.

Authors:  Merlin Nanayakkara; Giuliana Lania; Mariantonia Maglio; Renata Auricchio; Cristiana De Musis; Valentina Discepolo; Erasmo Miele; Bana Jabri; Riccardo Troncone; Salvatore Auricchio; Maria Vittoria Barone
Journal:  Sci Rep       Date:  2018-07-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.